다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Theratechnologies Inc (THTX)
Theratechnologies Inc (THTX) 뉴스

THTX

Theratechnologies (THTX)

Theratechnologies Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:THTX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/11	02:10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/05/10	06:26	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/05/10	05:30	GlobeNewswire Inc.	Theratechnologies Reports on its Annual Meeting of Shareholders	NASDAQ:THTX	Theratechnologies Inc
2024/05/02	20:30	GlobeNewswire Inc.	Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting	NASDAQ:THTX	Theratechnologies Inc
2024/04/16	05:15	GlobeNewswire Inc.	Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders	NASDAQ:THTX	Theratechnologies Inc
2024/04/11	20:30	GlobeNewswire Inc.	Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	NASDAQ:THTX	Theratechnologies Inc
2024/04/10	20:30	GlobeNewswire Inc.	Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024	NASDAQ:THTX	Theratechnologies Inc
2024/04/10	20:15	IH Market News	U.S. Index Futures Show Mixed Trend Ahead of Key Inflation Data Release, Oil Prices Edge Higher	NASDAQ:THTX	Theratechnologies Inc
2024/04/09	05:30	GlobeNewswire Inc.	Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology Platform	NASDAQ:THTX	Theratechnologies Inc
2024/04/06	00:00	GlobeNewswire Inc.	Theratechnologies Appoints Elina Tea to its Board of Directors	NASDAQ:THTX	Theratechnologies Inc
2024/04/03	20:30	GlobeNewswire Inc.	Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update	NASDAQ:THTX	Theratechnologies Inc
2024/03/28	20:30	GlobeNewswire Inc.	Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ Platform	NASDAQ:THTX	Theratechnologies Inc
2024/03/22	22:36	GlobeNewswire Inc.	Theratechnologies Announces Update on its Preclinical Oncology Research Program	NASDAQ:THTX	Theratechnologies Inc
2024/03/22	09:00	GlobeNewswire Inc.	Theratechnologies Appoints Jordan Zwick to its Board of Directors	NASDAQ:THTX	Theratechnologies Inc
2024/03/21	20:30	GlobeNewswire Inc.	Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer	NASDAQ:THTX	Theratechnologies Inc
2024/03/01	06:55	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/03/01	06:34	GlobeNewswire Inc.	Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau	NASDAQ:THTX	Theratechnologies Inc
2024/02/27	22:37	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/02/27	21:30	GlobeNewswire Inc.	Theratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDA	NASDAQ:THTX	Theratechnologies Inc
2024/02/21	22:01	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:THTX	Theratechnologies Inc
2024/02/21	22:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/02/21	21:30	GlobeNewswire Inc.	Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance	NASDAQ:THTX	Theratechnologies Inc
2024/02/20	21:30	GlobeNewswire Inc.	Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of Action	NASDAQ:THTX	Theratechnologies Inc
2024/02/15	22:36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/02/15	21:30	GlobeNewswire Inc.	Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer	NASDAQ:THTX	Theratechnologies Inc
2024/02/07	04:29	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/02/06	21:30	GlobeNewswire Inc.	Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update	NASDAQ:THTX	Theratechnologies Inc
2024/02/02	01:50	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/01/25	03:52	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:THTX	Theratechnologies Inc
2024/01/24	21:00	GlobeNewswire Inc.	Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA	NASDAQ:THTX	Theratechnologies Inc

검색 관련기사 보기:NASDAQ:THTX

1 2 3 4 5 6 7 8 9 10 다음 >>

Vontobel Financial Produ...

INTESA SANPAOLO

Intesa Sanpaolo

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관